🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

The wait is over—#HealthDataSummit is this week in Brussels! #SYNTHEMA joins the #HealthData4EU cluster panel on data quality in synthetic medical data. Sara Isabel Reidel (Vall d'Hebron Institut de Recerca) will share our approach. Meet us there! #SyntheticData #MedicalResearch

This week #SYNTHEMA's consortium partner Netcompany-Intrasoft will participate in the federated AI conference 'Flower AI Summit 2025' by ResearchFlowerLabs! Petros Demetrakopoulos & Sofia Tsekeridou will present on "A New P2P SMPC Protocol for FL using Flower" on March 27. Join us in London/online

Last week, #SYNTHEMA took part in a #HealthData4EU joint session at the Health Data Summit in Brussels. With the sickle-cell disease use case, Sara Reidel (Vall d'Hebron Institut de Recerca) presented our approach to AI-driven anonymisation, synthetic data & quality assessment to tackle data scarcity.

SYNTHEMA is at the #FlowerAISummit25. It’s amazing to see what you have built using 🌼Flower!

At #FlowerAISummit25, #SYNTHEMA’s Petros Demetrakopoulos & Sofia Tsekeridou presented our work on a P2P SMPC protocol for federated learning, advancing privacy-preserving #AI. Thanks to Flower for the platform to share and exchange insights!

Health data is fragmented—limiting research & innovation. That’s why 6 EU-funded projects—#SYNTHEMA, PHASE IV AI, Secured EU Project, FLUTE, PHEMS & AISym4MED - Health Horizon Europe Project—forces under #HealthData4EU to: ✅ Break data silos ✅ Enable AI-driven, privacy-first research More: synthema.eu

74% of haematological diseases are rare, yet underrepresented in research. At #SYNTHEMA, we’re using #AI & synthetic data generation to change that. By building a cross-border health data hub, we’re improving research & setting new standards in Europe. Learn more:

How can we improve predictions for rare diseases like sickle cell anemia? This #SYNTHEMA publication explores a new AI method that handles imbalanced medical data—one small step toward better tools for researchers. 🔗 bit.ly/4jc5nZt #AI #SyntheticData #RareDiseases

#SYNTHEMA links 16 partners in 10 countries to advance synthetic data for rare haematological diseases. Supported by ERN EuroBloodNet and key EU data platforms, the project focuses on secure, #AI-based clinical data sharing. 👉Learn more about us: synthema.eu

How is the EU addressing the challenges of Sickle Cell Disease? This paper co-authored by #SYNTHEMA partners explores the role of ERN EuroBloodNet in advancing care, collaboration & research for rare haematological diseases. 📄 Read more: bit.ly/44CHlSP #RareDiseases

In diseases like #leukemia or sickle cell, rare events can mean everything — but most #AI misses them. #SYNTHEMA goes deeper: our synthetic data captures those rare but life-saving patterns. Because in medicine, rare can save lives. 👉 synthema.eu

This #EuropeDay, we’re proud to support the EU’s vision for a healthier, more connected continent. With funding from the European Commission, #SYNTHEMA pioneers AI-powered synthetic data to improve diagnosis and treatment of rare blood diseases across Europe. 👉

#SYNTHEMA enters month 30 with a two-day consortium meeting in Ghent. Work package leaders are sharing milestones, next objectives, and aligning workflows for full collaboration between clinical and technical teams.

Just wrapped our 2-day #SYNTHEMA meeting—48 h of results, intense discussions & planning to validate AI-driven anonymisation & synthetic data for rare haematological diseases. Thanks to the i~HD & Nathan Lea! synthema.eu #HealthData #AI

It’s not enough for synthetic data to look real — it must be clinically useful. #SYNTHEMA tests if it can predict outcomes, reveal genetic risks & support real diagnoses. Synthetic data, real impact. 👉synthema.eu #SyntheticData #AIHealthcare

At #SYNTHEMA we use AI to fill data gaps & improve care for rare blood disorders. Focusing on Sickle Cell Disease & Acute Myeloid Leukaemia, we integrate clinical, genetic & imaging data for improved patient outcomes. 👉synthema.eu #RareDiseases #Haematology

#SYNTHEMA & GenoMed4All will be at #EHA2025 in Milan! Join us on June 13 for the Clinical & Data-Driven Research session by ERN EuroBloodNet, where partners will share insights on AI, data anonymisation & synthetic data for rare blood diseases. 👉Agenda: bit.ly/4dEGoMm

SYNTHEMA uses smart AI to study diseases like leukaemia and sickle cell without using real patient data. These models learn from medical records and create new, realistic examples — like lab results or scans — while keeping privacy fully protected. 👉 synthema.eu

The ERN-EuroBloodNet meeting will take place during the #EHA2025 Congress, the biggest event on hematology in Europe!​​🩸🌍 🎯If you are an ERN EuroBloodNet Member, Affiliated partner or ePAG, don't miss this opportunity! ​🔗​Info and registrations: bit.ly/4dGtUnj